Divestments
Aelin Therapeutics
Novel therapeutic modality to induce functional knockdown of a target protein.
Key Facts
- Sector
Life Sciences
- Country
Belgium
- Fund
LSP 5
- Entry
2017
- Exit
2023
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.